Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › bicalutamide

bicalutamide

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of bicalutamide

34 trials tracked of bicalutamide: 10 in phase 3 or 4 and 1 with published results. The most-cited published study has 41 citations.

34Trials tracked
10Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 3 9 Phase 2 23 Phase 1 1
  1. Phase 3 Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Completed · 41 cited
  2. Phase 4 Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy Completed
  3. Phase 3 Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy Completed
  4. Phase 3 Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer Completed
  5. Phase 3 SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer Completed
  6. Phase 3 S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Completed
Show 28 more trials
  1. Phase 3 S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer Completed
  2. Phase 3 Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients Completed
  3. Phase 3 A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer Completed
  4. Phase 3 Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer Completed
  5. Phase 2 A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer Completed
  6. Phase 2 A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer Completed
  7. Phase 2 Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer Completed
  8. Phase 2 Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration Completed
  9. Phase 2 A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer Completed
  10. Phase 2 Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy Completed
  11. Phase 2 A Study of Definitive Therapy to Treat Prostate Cancer Completed
  12. Phase 2 Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis] Completed
  13. Phase 2 S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer Completed
  14. Phase 2 Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy Completed
  15. Phase 2 LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer Completed
  16. Phase 2 Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate Cancer Completed
  17. Phase 2 Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer Completed
  18. Phase 2 RAD001 and Bicalutamide for Androgen Independent Prostate Cancer Completed
  19. Phase 2 Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer Completed
  20. Phase 2 Bicalutamide in Treating Patients With Metastatic Breast Cancer Completed
  21. Phase 2 Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer Completed
  22. Phase 2 R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer Completed
  23. Phase 2 Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy Completed
  24. Phase 2 A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy Completed
  25. Phase 2 Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer Completed
  26. Phase 2 Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer Completed
  27. Phase 2 Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle Completed
  28. Phase 1 Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex® 50 mg Tablet in Healthy Subjects Under Fed Conditions Completed

Showing the 34 most-cited and recently-updated of 34 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.